Laura Benjamin
Directeur/Membre du Conseil chez ALLARITY THERAPEUTICS, INC.
Postes actifs de Laura Benjamin
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| ALLARITY THERAPEUTICS, INC. | Directeur/Membre du Conseil | - | - |
| Independent Dir/Board Member | - | - | |
Oncxerna Therapeutics, Inc.
 Oncxerna Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Oncxerna Therapeutics, Inc. develops oncology drugs. The firm uses RNA-based biomarker platform. It focuses on clinical-stage therapies. The company was founded by Laura E. Benjamin in 2018 and is headquartered in Boston, MA. | Directeur/Membre du Conseil | 01/01/2018 | - |
| Directeur Général | 01/01/2018 | - | |
| Fondateur | 01/01/2018 | - | |
| President | 01/01/2018 | - | |
Allarity Therapeutics A/S
 Allarity Therapeutics A/S Pharmaceuticals: MajorHealth Technology Allarity Therapeutics A/S is a biotechnology company, which engages in the research and development of anti-cancer drugs. Its product pipeline includes LiPlaCis, 2X-121, 2X-111, irofulven phase 2, and APO010.The company was founded by Steen Meier Knudsen and Peter Buhl Jensen in 2004 and is headquartered in Hoersholm, Denmark. | Directeur/Membre du Conseil | - | - |
| Independent Dir/Board Member | - | - |
Historique de carrière de Laura Benjamin
Formation de Laura Benjamin
| University of Pennsylvania | Doctorate Degree |
| Barnard College | Undergraduate Degree |
Statistiques
Internationale
| Etats-Unis | 5 |
| Danemark | 2 |
Opérationnelle
| Director/Board Member | 3 |
| Independent Dir/Board Member | 2 |
| Chief Executive Officer | 1 |
Sectorielle
| Health Technology | 4 |
| Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ALLARITY THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Oncxerna Therapeutics, Inc.
Oncxerna Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Oncxerna Therapeutics, Inc. develops oncology drugs. The firm uses RNA-based biomarker platform. It focuses on clinical-stage therapies. The company was founded by Laura E. Benjamin in 2018 and is headquartered in Boston, MA. | Health Technology |
Allarity Therapeutics A/S
Allarity Therapeutics A/S Pharmaceuticals: MajorHealth Technology Allarity Therapeutics A/S is a biotechnology company, which engages in the research and development of anti-cancer drugs. Its product pipeline includes LiPlaCis, 2X-121, 2X-111, irofulven phase 2, and APO010.The company was founded by Steen Meier Knudsen and Peter Buhl Jensen in 2004 and is headquartered in Hoersholm, Denmark. | Health Technology |
- Bourse
- Insiders
- Laura Benjamin
- Expérience
